Kitasamycin

Star0

DB09309ExperimentalSmall molecule

Kitasamycin is a macrolide antibiotic derived from Streptomyces kitasatoensis.

Mechanism: Pharmacologically active on E3 ubiquitin-protein ligase HUWE1
Curator reviewed
Formula / weight: C₄₀H₆₇NO₁₄ · 785.969 g/mol (avg)
Also known as: Leucomycin

Resolves to

Compound

UNIIYX09Z4QW5YCAS1392-21-8ChEMBLCHEMBL2106399ChEBI34812PubChem5282322KEGGC14056

Structure

InChIKeyIEMDOFXTVAPVLX-YWQHLDGFSA-NSMILES

CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C

Targets

Q7Z6Z7HUWE1

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

317Drug interactionsStructured to mechanism, not free text

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Kitasamycin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account